Variant report
Variant | esv3343515 |
---|---|
Chromosome Location | chr4:100617029-100621427 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:100618918..100621317-chr4:100629954..100633305,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75529623 | chr4:100617045-100617046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs562209967 | chr4:100617156-100617157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564814616 | chr4:100617163-100617164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576630199 | chr4:100617165-100617166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544070121 | chr4:100617181-100617182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562175635 | chr4:100617260-100617261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs141589062 | chr4:100617287-100617288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs150447394 | chr4:100617358-100617359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs386677748 | chr4:100617378-100617379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs370158237 | chr4:100617384-100617385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs138264344 | chr4:100617385-100617386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs553760894 | chr4:100617392-100617393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533373077 | chr4:100617449-100617450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551459891 | chr4:100617606-100617607 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs71614608 | chr4:100617611-100617612 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs531542291 | chr4:100617625-100617626 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs550039931 | chr4:100617634-100617635 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533476578 | chr4:100617695-100617696 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs567964151 | chr4:100617742-100617743 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551945804 | chr4:100617772-100617773 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181503880 | chr4:100617787-100617788 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs78152550 | chr4:100617797-100617798 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs35004975 | chr4:100617838-100617839 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535228206 | chr4:100617947-100617948 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553462442 | chr4:100617948-100617949 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs17029334 | chr4:100617956-100617957 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs539438749 | chr4:100617972-100617973 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557494770 | chr4:100618001-100618002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533146807 | chr4:100618031-100618032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552462851 | chr4:100618032-100618033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186280228 | chr4:100618081-100618082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs6815796 | chr4:100618105-100618106 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs556021629 | chr4:100618106-100618107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190699269 | chr4:100618134-100618135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs369390649 | chr4:100618139-100618140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs541596131 | chr4:100618193-100618194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs559901425 | chr4:100618202-100618203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs55995913 | chr4:100618231-100618232 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs545469554 | chr4:100618281-100618282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs35215295 | chr4:100618297-100618298 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs530930692 | chr4:100618308-100618309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs149626318 | chr4:100618327-100618328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113490300 | chr4:100618350-100618351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529071775 | chr4:100618378-100618379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs60228486 | chr4:100618385-100618386 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs372019014 | chr4:100618391-100618392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565514554 | chr4:100618410-100618411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539189518 | chr4:100618459-100618460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs141906704 | chr4:100618460-100618461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs72901515 | chr4:100618465-100618466 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Melanoma | 20688739 | CNVD |
Gastric cancer | 16891809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:100612800-100618000 | Weak transcription | Psoas Muscle | Psoas |
2 | chr4:100617600-100618800 | Enhancers | Skeletal Muscle Male | skeletal muscle |
3 | chr4:100617600-100619000 | Enhancers | Fetal Muscle Leg | muscle |
4 | chr4:100618000-100618800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
5 | chr4:100618000-100619000 | Enhancers | Psoas Muscle | Psoas |
6 | chr4:100618600-100619000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr4:100619000-100620000 | Weak transcription | Fetal Muscle Leg | muscle |
8 | chr4:100620000-100620600 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr4:100620200-100620400 | Enhancers | Fetal Muscle Leg | muscle |